
Alpesh Shah
Examiner (ID: 405)
| Most Active Art Unit | 2302 |
| Art Unit(s) | 2756, 2302, 2783, 2315 |
| Total Applications | 455 |
| Issued Applications | 326 |
| Pending Applications | 23 |
| Abandoned Applications | 106 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1137638
[patent_doc_number] => 06780609
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-24
[patent_title] => 'High bone mass gene of 1.1q13.3'
[patent_app_type] => B1
[patent_app_number] => 09/543771
[patent_app_country] => US
[patent_app_date] => 2000-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 36
[patent_no_of_words] => 97277
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780609.pdf
[firstpage_image] =>[orig_patent_app_number] => 09543771
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/543771 | High bone mass gene of 1.1q13.3 | Apr 4, 2000 | Issued |
Array
(
[id] => 6414440
[patent_doc_number] => 20020038465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Non-human animal mutants and methods for production of the same'
[patent_app_type] => new
[patent_app_number] => 09/539526
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2857
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20020038465.pdf
[firstpage_image] =>[orig_patent_app_number] => 09539526
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539526 | Non-human animal mutants and methods for production of the same | Mar 29, 2000 | Abandoned |
Array
(
[id] => 1377248
[patent_doc_number] => 06563016
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses'
[patent_app_type] => B1
[patent_app_number] => 09/536231
[patent_app_country] => US
[patent_app_date] => 2000-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 25545
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/563/06563016.pdf
[firstpage_image] =>[orig_patent_app_number] => 09536231
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/536231 | Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses | Mar 26, 2000 | Issued |
Array
(
[id] => 4383769
[patent_doc_number] => 06303845
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'HS-40 enhancer-containing vector'
[patent_app_type] => 1
[patent_app_number] => 9/536094
[patent_app_country] => US
[patent_app_date] => 2000-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4022
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303845.pdf
[firstpage_image] =>[orig_patent_app_number] => 536094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/536094 | HS-40 enhancer-containing vector | Mar 23, 2000 | Issued |
| 09/516493 | Novel glucose transporter/sensor protein and uses thereof | Feb 29, 2000 | Abandoned |
| 09/514066 | Formulations and methods for using the same to elicit and immune response | Feb 24, 2000 | Abandoned |
Array
(
[id] => 1240778
[patent_doc_number] => 06682745
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Use of bacterium for manufacture of a vaccine'
[patent_app_type] => B1
[patent_app_number] => 09/492206
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2858
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/682/06682745.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492206
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492206 | Use of bacterium for manufacture of a vaccine | Jan 26, 2000 | Issued |
Array
(
[id] => 1082779
[patent_doc_number] => 06833252
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-21
[patent_title] => 'Nucleotide sequence encoding the enzyme I-SecI and the uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/492697
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 64
[patent_no_of_words] => 24211
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/833/06833252.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492697 | Nucleotide sequence encoding the enzyme I-SecI and the uses thereof | Jan 26, 2000 | Issued |
Array
(
[id] => 1336229
[patent_doc_number] => 06589505
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Cells that lack p19ink4d and p27kip1 activity and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/483597
[patent_app_country] => US
[patent_app_date] => 2000-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 30
[patent_no_of_words] => 20052
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589505.pdf
[firstpage_image] =>[orig_patent_app_number] => 09483597
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/483597 | Cells that lack p19ink4d and p27kip1 activity and methods of use thereof | Jan 13, 2000 | Issued |
Array
(
[id] => 1439341
[patent_doc_number] => 06495131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-17
[patent_title] => 'Interleukin-3 gene therapy for cancer'
[patent_app_type] => B1
[patent_app_number] => 09/481201
[patent_app_country] => US
[patent_app_date] => 2000-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15936
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09481201
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481201 | Interleukin-3 gene therapy for cancer | Jan 10, 2000 | Issued |
Array
(
[id] => 582066
[patent_doc_number] => 07445890
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-11-04
[patent_title] => 'Ucp-2 promoter and use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/869098
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7115
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/445/07445890.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869098
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869098 | Ucp-2 promoter and use thereof | Dec 21, 1999 | Issued |
Array
(
[id] => 668326
[patent_doc_number] => 07094565
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-22
[patent_title] => '21612, novel human dehydrogenases'
[patent_app_type] => utility
[patent_app_number] => 09/464039
[patent_app_country] => US
[patent_app_date] => 1999-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 22
[patent_no_of_words] => 33961
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094565.pdf
[firstpage_image] =>[orig_patent_app_number] => 09464039
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464039 | 21612, novel human dehydrogenases | Dec 14, 1999 | Issued |
Array
(
[id] => 1415264
[patent_doc_number] => 06506378
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-14
[patent_title] => 'Vesicular monoamine transporter gene therapy in Parkinson\'s disease'
[patent_app_type] => B1
[patent_app_number] => 09/461793
[patent_app_country] => US
[patent_app_date] => 1999-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 24
[patent_no_of_words] => 26527
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506378.pdf
[firstpage_image] =>[orig_patent_app_number] => 09461793
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/461793 | Vesicular monoamine transporter gene therapy in Parkinson's disease | Dec 14, 1999 | Issued |
| 09/456357 | VIRAL VECTORS ENCODING APOPTOSIS-INDUCING PROTEINS AND METHODS FOR MAKING AND USING THE SAME | Dec 7, 1999 | Abandoned |
Array
(
[id] => 1587451
[patent_doc_number] => 06482403
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Caniney IL-13 immunoregulatory proteins and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/451527
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80840
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482403.pdf
[firstpage_image] =>[orig_patent_app_number] => 09451527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/451527 | Caniney IL-13 immunoregulatory proteins and uses thereof | Nov 30, 1999 | Issued |
| 09/452140 | INTERLEUKIN-1 HOMOLOGUE, MAT IL-1H4 | Nov 30, 1999 | Abandoned |
Array
(
[id] => 6769482
[patent_doc_number] => 20030215422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'AAV4 VECTOR AND USES THEREOF'
[patent_app_type] => new
[patent_app_number] => 09/254747
[patent_app_country] => US
[patent_app_date] => 1999-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15198
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215422.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254747
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254747 | AAV4 VECTOR AND USES THEREOF | Nov 25, 1999 | Abandoned |
Array
(
[id] => 1387350
[patent_doc_number] => 06540995
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Encapsulated cells producing cytochrome P450'
[patent_app_type] => B1
[patent_app_number] => 09/442979
[patent_app_country] => US
[patent_app_date] => 1999-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11909
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/540/06540995.pdf
[firstpage_image] =>[orig_patent_app_number] => 09442979
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442979 | Encapsulated cells producing cytochrome P450 | Nov 17, 1999 | Issued |
Array
(
[id] => 1358438
[patent_doc_number] => 06576813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-10
[patent_title] => 'Knockout animals'
[patent_app_type] => B2
[patent_app_number] => 09/355405
[patent_app_country] => US
[patent_app_date] => 1999-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6244
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576813.pdf
[firstpage_image] =>[orig_patent_app_number] => 09355405
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/355405 | Knockout animals | Nov 17, 1999 | Issued |
Array
(
[id] => 798015
[patent_doc_number] => 07427602
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-23
[patent_title] => 'Sustained DNA delivery from structural matrices'
[patent_app_type] => utility
[patent_app_number] => 09/442542
[patent_app_country] => US
[patent_app_date] => 1999-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 43970
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427602.pdf
[firstpage_image] =>[orig_patent_app_number] => 09442542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442542 | Sustained DNA delivery from structural matrices | Nov 17, 1999 | Issued |